MOS testbed for the characterization of targeted alpha therapy pharmaceuticals

From National Research Council Canada

DOIResolve DOI: http://doi.org/10.1109/JSEN.2014.2365412
AuthorSearch for: ; Search for: ; Search for: ; Search for:
TypeArticle
Journal titleIEEE Sensors Journal
ISSN1530-437X
1558-1748
Volume15
Issue3
Pages16901696
Subjectpharmaceutical development; Metal-Oxide-Semiconductor; MOS; Radioimmunotherapy; RIT; Targeted Alpha Therapy; TAT; Targeted Radionuclide Therapy; TRT; aptamer; DNA; chelator characterization; DOTA
Abstract
Publication date
LanguageEnglish
AffiliationNational Research Council Canada; Information and Communication Technologies
Peer reviewedYes
NPARC number23001036
Export citationExport as RIS
Report a correctionReport a correction
Record identifier7445addb-c992-4ef5-9a3a-94762dbba3b9
Record created2016-12-02
Record modified2016-12-02
Date modified: